Eli Lilly and Co
LLY · Healthcare · Pharmaceuticals
Updated 24 min ago · data delayed ≥15 min
Iconic Score
ProprietaryRanked #9 of 503 by Iconic Score · #1 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a blend of scale, market attention, and category leadership.
Iconic Profile
Eli Lilly and Co (LLY) is a leading global pharmaceutical company specializing in the discovery, development, and commercialization of innovative medicines across various therapeutic areas, including diabetes, oncology, immunology, and neurodegeneration. With a market capitalization of $1119.3 billion, Lilly holds a strong position in the healthcare sector, driven by its robust pipeline of new drugs and a commitment to research and development. The company is recognized for its significant contributions to improving patient outcomes and addressing unmet medical needs, making it a key player in the pharmaceutical industry. Lilly's strategic focus on biopharmaceuticals and personalized medicine underscores its relevance in a rapidly evolving healthcare landscape, as it seeks to enhance the quality of life for patients worldwide.
Enterprise tier: claim your logo to manage how your brand is represented.